Around 1 in 10 babies are in need of some form of stabilisation at birth. The heart rate of the baby is critical for guiding the stabilisation or resuscitation process; however current monitoring methods do not always provide an early enough or sometimes an accurate enough heart rate. This can lead to uncertainty in the management of the baby’s care.
What we do
Accurate, rapid measurements benefit clinical staff by enabling them to make confident decisions more quickly and to focus on performing procedures in time critical situations.
SurePulse may help reduce the time patients spend in neonatal intensive care and reduce costs for healthcare organisations.
Babies born in Europe every year need some form of resuscitation
Learn moreWhat this means
About one in ten babies need some form of help in the first few minutes after birth to stimulate breathing and to ensure the heart is beating properly. That adds up to a staggering 80,000 babies in the UK, more than 200 each day, and 14 million worldwide each year.
Learn more
Great to see @UoNresearch spinouts and partners as finalists in @MedilinkEM Business Awards @NuVisBio @SurePulseMed @footfalls_uk @UoN_NIA @MedicineUoN @UoNEngineering Good luck to all! https://t.co/YMNl6BZetH
Great few days at #jENScongress demonstrating the SurePulse VS. Excited to welcome you to our stand if you haven't already been!
It's our 1st birthday at #Medicity and 5th Birthday as a company. Day of celebrations! #cake
SurePulse are proud to be supporting the @NeonatalSociety 60th anniversary meeting in Cambridge. Visit our stand to learn more about new approaches to monitoring the newborn during stabilisation
